
-
2008
Company Description
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous or infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was incorporated in 2007 and is based in Abingdon, United Kingdom.
-
Manufacturer:
Science and Engineering -
Formed:
2008 -
Founders:
Ian Laing -
Company Website:
-
Company E-mail:
-
Company Address:
91 Park Drive,Milton Park, AbingdonUnited KingdomOxton -
CEO:
- Ian Laing
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits